Embecta announces new publication in Mayo Clinic Proceedings on FITTER

Embecta (EMBC) announced a new publication in the Mayo Clinic Proceedings. The publication introduces the FITTER Forward Expert Recommendations, an updated set of global best practices for insulin injection technique and education. Authored by a panel of 16 diabetes specialists from 13 countries, the FITTER Forward initiative highlights the critical need for improved training and standardization in insulin delivery, aiming to enhance clinical outcomes for millions of people with diabetes worldwide. “As a company dedicated to advancing diabetes care for more than 100 years, embecta is proud to support the FITTER Forward initiative,” said Dr. Pasha Javadi, Senior Director, Global Medical Affairs at embecta. “Proper injection technique is a fundamental aspect of medicine delivery-whether it’s insulin, GLP-1s, or other injectable therapies. By empowering healthcare professionals with the latest research-backed recommendations, we can help improve patient outcomes and ensure that injection therapy is as effective and comfortable as possible.”